IBD

Beyond's analysis on IBD

• 2026-06-25 — Indivior’s IBD 50 inclusion triggers breakout as institutional ownership expands and profit outlook improves
• 2026-06-23 — IBD highlights a pawnshop operator's strategic 'kingly move,' signaling potential investor interest
• 2026-06-15 — Corning’s AI‑driven data center and photonics growth makes it a pivotal player in the emerging AI infrastructure boom

Recent news mentioning IBD

• 2026-09-22 — Micron, IBD Stock Of The Day, Surges Past Early Buy Point With Earnings Ahead
• 2026-09-22 — Palisade Bio Receives FDA Clearance of IND for PALI-2108 in Crohn’s Disease, Expanding Phase 2 Development Across IBD
• 2026-09-18 — When To Dump Stocks: These IBD 50 Components Hit Sell Signals
• 2026-09-18 — IBD Stock Of The Day Eyes Buy Points As Investors Dig Into Its Pipeline
• 2026-09-17 — Spyre (SYRE) Clears Monotherapy Phase for IBD Portfolio, Setting Up Combination Tests
• 2026-09-16 — AMD, IBD Stock Of The Day, Gains As Heavyweights Dismiss AI Slowdown
• 2026-09-15 — IBD Stock Of The Day Scorpio Tankers Sails Toward Buy Point As Oil-Needy World Seeks Its Services
• 2026-09-14 — Chili's Stays Hot. Its Owner Is IBD's Stock Of The Day.
• 2026-09-11 — Exelixis, An IBD 50 Stock, Pulls A Bearish Move With Surprise Cancer Delay
• 2026-09-11 — When To Sell Stocks: Why Investors May Want To Walk Away From These IBD 50 Stocks
• 2026-09-10 — Apple, IBD Stock Of The Day, Rebounds Bullishly After iPhone Duo Debut
• 2026-09-09 — AMD, IBD Stock Of The Day, Runs Past Early Buy Point As Chipmaker Returns To Favor

Appears alongside

• AMD
• Micron
• FDA
• IND
• SYRE
• Apple
• TSMC
• HTK
• ServiceNow
• SaaSpocalypse
• Nvidia
• Eli Lilly
• Amazon

Browse the full archive →